Seeking Alpha

NeurAxis Announces Results of Comparative Study of IB-Stim™ and Standard Medical Therapy in Adolescents with Functional Abdominal Pain Disorders

CARMEL, Ind., Sept. 26, 2023 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies that ...
Seeking Alpha

NeurAxis Highlights Two Independent Studies Showing Benefits of IB-Stim in Adolescents Involving the Gut Microbiome

CARMEL, Ind., Aug. 22, 2023 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (NYSE American: NRXS), (“NeurAxis,” or the “Company”), a medical technology company commercializing neuromodulation therapies that ...
Business Wire

Electromedical Products International (EPI) Expands Access of Unique Medical Technology to Veterans Experiencing Anxiety, Insomnia, Pain

BOSTON--(BUSINESS WIRE)--In recognition of Veterans Day, AcuityMD announces its partnership with Electromedical Products International (EPI) to drive access to Alpha-Stim ®, a non-invasive, ...
Psychology Today

EMDR Therapists in Milton, DE

I am Alpha-Stim trained and EMDR trained. Hello! I am Shamaya Hagan and I am an LMSW in Delaware that provides in-office and telehealth clinical therapy. I work with adolescent and adult clients who ...
Nasdaq

NeurAxis, Inc. Expands Insurance Coverage for IB-Stim Therapy, Enhancing Access for Patients with Abdominal Pain

NeurAxis, Inc. has announced new medical policy coverage for its Percutaneous Electrical Nerve Field Stimulation (PENFS) technology, specifically the IB-Stim device, by two health insurers in ...